Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Thorin

Showing results (11-20 of 114) with videos related to

Pageof 12
Sort By:
Journal of the American College of Cardiology|November 3, 2022
Inhibition of the Mechanistic Target of Rapamycin in Acute Myocardial InfarctionJean-Claude Tardif, Eric Thorin
Cardiovascular Research|July 10, 2009
Vascular endothelial ageing, heartbeat after heartbeatEric Thorin, Nathalie Thorin-Trescases
Cardiovascular Research|January 9, 2010
HO-1, a new target of PPARdelta with 'anti-atherogenic' properties: is it the one?Nathalie Thorin-Trescases, Eric Thorin
The Canadian Journal of Cardiology|March 11, 2016
Lifelong Cyclic Mechanical Strain Promotes Large Elastic Artery Stiffening: Increased Pulse Pressure and Old Age-Related Organ FailureNathalie Thorin-Trescases, Eric Thorin
Expert Reviews in Molecular Medicine|November 25, 2014
Angiopoietin-like-2: a multifaceted protein with physiological and pathophysiological propertiesNathalie Thorin-Trescases, Eric Thorin
Oxidative Medicine and Cellular Longevity|November 16, 2017
High Circulating Levels of ANGPTL2: Beyond a Clinical Marker of Systemic InflammationNathalie Thorin-Trescases, Eric Thorin
Pflugers Archiv : European Journal of Physiology|December 8, 2009
Endothelium-derived endothelin-1Eric Thorin, David J Webb
American Journal of Physiology. Heart and Circulatory Physiology|July 24, 2007
A change in the redox environment and thromboxane A2 production precede endothelial dysfunction in miceMarie-Eve Gendron, Eric Thorin
The Canadian Journal of Cardiology|December 3, 2021
The Quest for a Biomarker of Premature Biological AgingEric Thorin, Nathalie Thorin-Trescases
Journal of Hypertension|December 4, 2014
Neuroprotection after ischemic stroke by activation of angiotensin receptor type 2: why clinical data do not fit the paradigm?Eric Thorin, Giovanna Castoldi, Andrea Stella
Pageof 12

Showing results (11-20 of 114) with videos related to

Sort By:
Pageof 12
Journal of the American College of Cardiology|November 3, 2022
Inhibition of the Mechanistic Target of Rapamycin in Acute Myocardial InfarctionJean-Claude Tardif, Eric Thorin
Cardiovascular Research|July 10, 2009
Vascular endothelial ageing, heartbeat after heartbeatEric Thorin, Nathalie Thorin-Trescases
Cardiovascular Research|January 9, 2010
HO-1, a new target of PPARdelta with 'anti-atherogenic' properties: is it the one?Nathalie Thorin-Trescases, Eric Thorin
The Canadian Journal of Cardiology|March 11, 2016
Lifelong Cyclic Mechanical Strain Promotes Large Elastic Artery Stiffening: Increased Pulse Pressure and Old Age-Related Organ FailureNathalie Thorin-Trescases, Eric Thorin
Expert Reviews in Molecular Medicine|November 25, 2014
Angiopoietin-like-2: a multifaceted protein with physiological and pathophysiological propertiesNathalie Thorin-Trescases, Eric Thorin
Oxidative Medicine and Cellular Longevity|November 16, 2017
High Circulating Levels of ANGPTL2: Beyond a Clinical Marker of Systemic InflammationNathalie Thorin-Trescases, Eric Thorin
Pflugers Archiv : European Journal of Physiology|December 8, 2009
Endothelium-derived endothelin-1Eric Thorin, David J Webb
American Journal of Physiology. Heart and Circulatory Physiology|July 24, 2007
A change in the redox environment and thromboxane A2 production precede endothelial dysfunction in miceMarie-Eve Gendron, Eric Thorin
The Canadian Journal of Cardiology|December 3, 2021
The Quest for a Biomarker of Premature Biological AgingEric Thorin, Nathalie Thorin-Trescases
Journal of Hypertension|December 4, 2014
Neuroprotection after ischemic stroke by activation of angiotensin receptor type 2: why clinical data do not fit the paradigm?Eric Thorin, Giovanna Castoldi, Andrea Stella
Pageof 12